OTINasdaqinactive

OXYGEN THERAPY, INC.

Healthcare·Healthcare·Pre-clinical

OXYGEN THERAPY, INC. (OTI): 37 pipeline candidates. Updated within the last hour.

10.0/10

BioSniper Score

2-factor signal · derived from public data

Cash RunwayN/A

N/A

Financial Health10.0

0% dilution

Pipeline MaturityN/A

N/A

Pipeline Breadth10.0

37 candidates

Catalyst MomentumN/A

N/A

Insider SignalN/A

N/A

A transparent, data-derived signal for OXYGEN THERAPY, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.

Key Financials

Market Cap

—

Cash

—

Quarterly Burn

$125K

Runway

—

Revenue

—

Pipeline (37 candidates)

Drug	Phase	Indication
1160 simple isolation valve & 1161 filtered valve	—	—
5300 percussor	—	—
aerosol effusion system #1740	—	—
air compressor adaptor kit	—	—
airway	—	—
bacteria filter	—	—
c.p.a.p. nasal cannula	—	—
catalog 6400 oxygen concentrator	—	—
catalog no. 1755 1s0-neb	—	—
disposable bite block/tongue depressor	—	—

Showing 10 of 37 candidates. Sign up for full pipeline.

Get the full picture on OXYGEN THERAPY, INC.

Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.

Start Free Analysis Browse Calendar